Elevated Expression of Lipoprotein-Associated Phospholipase A2 in Calcific Aortic Valve Disease
Ablajan Mahmut(Valve (United States)), Patrick Mathieu(Institut universitaire de cardiologie et de pneumologie de Québec), Dominique Fournier(Institut universitaire de cardiologie et de pneumologie de Québec), Diala El Husseini(Université Laval), Rihab Bouchareb(Temple University), Marie‐Chloé Boulanger(Institut universitaire de cardiologie et de pneumologie de Québec), Jean‐Pierre Després(Université Laval), Yohan Bossé(Institut universitaire de cardiologie et de pneumologie de Québec), Philippe Pîbarot(Emory University)
Cited by 124
Related Papers
Sugar-Sweetened Beverages and Risk of Metabolic Syndrome and Type 2 Diabetes
|Diabetes Care|2010|2.1k
Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity
|Nature Reviews Endocrinology|2020|1.8k
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
|Circulation|2023|1.7k
Abdominal Obesity and the Metabolic Syndrome: Contribution to Global Cardiometabolic Risk
|Arteriosclerosis Thrombosis and Vascular Biology|2008|1.6k
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.3k